FRANKLIN LAKES, N.J., March 14, 2012 /PRNewswire/ --The final results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) study will be presented at the American College of Cardiology's 61st Annual Scientific Session & Expo being held March 24-27, 2012, in Chicago, IL. The AKROBATS study is a collaborative effort between the Medco Research Institute, a subsidiary of Medco Health Solutions, Inc. (NYSE: MHS - News) and Quest Diagnostics (NYSE: DGX - News), the world's leading diagnostic testing company.
(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO )
Presentation Details
Session Number: 1258
Session Type: ACC Moderated Poster Contributions
Session Start/End Time: Monday, Mar 26, 2012, 9:30 AM -10:30 AM
Location: McCormick Place South, Hall A
Presentation Number: 1258-376
Abstract Title: Patient knowledge of pharmacogenetic information improves adherence to statin therapy: Results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.
Presenter: Scott L. Charland, Pharm.D., Medco Research Institute
Follow this link:
Medco to Present Results of National Study on Effect of Genetic Testing on Patient Medication Adherence at the ...
Recommendation and review posted by G. Smith
